Business Wire

iFIT Inc. Announces the Launch of its Science Council to Advance Personalization and Fitness Innovation

Share

iFIT Inc., a global leader in intelligent, personalized fitness, is proud to announce the formation of the iFIT Science Council, a pioneering initiative designed to integrate cutting-edge scientific insights into the company’s product development, content strategy, and member experience.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250528148121/en/

New advisory council of leading scientists will guide iFIT’s platform, integrating fitness insights and wellness technology for science-backed workouts.

Composed of leading experts across wellness disciplines, the Science Council will further elevate iFIT’s leadership in personalized fitness and holistic health solutions. The inaugural members of iFIT’s Science Council include members of the medical and science community who specialize in a range of focus areas including longevity, women’s health, cognitive performance, and sleep: Dr. Darshan Shah, Mona Sharma, Louisa Nicola, Dr. Michael Breus, Dr. Duncan French, Dr. Vonda Wright, and Dr. Rangan Chatterjee.

Expert Council to Drive Fitness Innovation

By leveraging the latest findings in health and human performance, the Council will help iFIT deliver fitness innovation that is firmly grounded in science while remaining accessible and engaging for consumers.

“Health and wellness journeys are deeply personal—each of us starts from a different place, but we’re unified by a common goal: to live healthier lives,” said Kevin Duffy, CEO of iFIT. “The challenge is knowing where to begin, how to adapt, and what truly works. With rapid advancements across exercise science, physiology, and health optimization, we now have powerful tools to guide these journeys. The iFIT Science Council allows us to translate that science into actionable, everyday routines—making the fundamentals of fitness more accessible, personal, and impactful for millions of members around the world.”

Integrating Biomarkers and Wellness Tech

A core focus of the council is to bridge the gap between high-level health science and everyday workouts. The advisors will help iFIT interpret and apply insights from fields like exercise physiology, metabolism, and genetics into its product development. For example, iFIT plans to integrate deeper biometric tracking and biomarker fitness insights into its platform – leveraging data such as heart-rate variability, recovery metrics, and other health signals – to further customize each user’s workout plan. By infusing iFIT’s interactive training programs with this data-driven approach, the Science Council will enable the company to refine how workouts adapt in real time to an individual’s performance and wellness profile.

“One-size-fits-all workouts are a thing of the past. By harnessing real biomarker data and the latest scientific research, we can tailor truly science-backed workouts to each individual,” said Dr. Darshan Shah, iFIT’s Chief Medical Advisor. “The Science Council brings together leading minds in sports medicine, nutrition, and technology to transform our approach to connected fitness. Together, we’ll help iFIT members to achieve better results through personalized, evidence-based training.”

The establishment of the iFIT Science Council reinforces the company’s commitment to continuous innovation, empowering users to achieve their health and fitness goals through scientifically-backed insights and technology-driven personalization.

To experience iFIT’s science-driven, personalized workouts first-hand or learn more about the iFIT platform, visit www.iFIT.com.

iFIT Inaugural Science Council Members

Dr. Darshan Shah – Chief Medical Advisor, Longevity & Health Optimization Expert

Dr. Darshan Shah is a board-certified surgeon, longevity specialist, and founder of Next Health—the world’s largest health optimization and longevity clinic. With over 20,000 surgical procedures to his name, Dr. Shah shifted his focus to preventive health after reversing his own autoimmune disease and losing 50 pounds through lifestyle changes. A graduate of Harvard Business School and Singularity University, he now leads innovation in biomarker-driven wellness and personalized health protocols. ​

Mona Sharma – Holistic Nutritionist & Wellness Strategist

Mona Sharma is a globally recognized nutritionist and wellness entrepreneur known for integrating Ayurvedic principles with modern science. As the founder of Xicama™ and host of the “Rooted in Wellness” podcast, she has transformed the lives of high-profile clients—including Will Smith and Julianne Hough—by creating personalized health strategies that blend nutrition, mindfulness, and lifestyle practices.

Louisa Nicola – Neurophysiologist & Cognitive Performance Coach

Louisa Nicola is a neurophysiologist and founder of Neuro Athletics, a consulting firm that optimizes brain performance for elite athletes in the NBA, NFL, and MLB, as well as Wall Street executives. A former professional triathlete, she combines neuroscience with athletic training to enhance cognitive function, utilizing EEG scans, lab tests, and cognitive assessments. Louisa is also the host of “The Neuro Experience” podcast, where she explores brain health, longevity, and peak performance. ​

Dr. Michael Breus – Clinical Psychologist & Sleep Medicine Expert

Dr. Michael Breus, known as “The Sleep Doctor,” is a double board-certified clinical psychologist and sleep specialist. One of only 168 psychologists worldwide to pass the Sleep Medicine Boards without attending medical school, he has authored best-selling books like “The Power of When.” Dr. Breus has been a prominent media figure, sharing his expertise on platforms such as The Today Show, Dr. Oz, and Oprah, and served as the sleep expert for WebMD for 14 years.

Dr. Duncan French – High-Performance Sport Scientist

Dr. Duncan French is the Senior Vice President of the UFC Performance Institute, bringing over 20 years of experience in elite sports performance. He has coached athletes across more than 40 professional and Olympic sports, including roles as Director of Performance Sciences at the University of Notre Dame and Technical Lead for Strength & Conditioning at the English Institute of Sport. Dr. French is renowned for his expertise in strength and conditioning, training transfer, and performance optimization. ​

Dr. Vonda Wright – Orthopedic Surgeon & Women’s Health Advocate

Dr. Vonda Wright, MD is a pioneering orthopedic sports surgeon, researcher, an expert in human performance, longevity, and an authority in women's health. Dr Wright is a frequent media and conference expert, and her science-based approach is changing the lives of millions in mid-life. Dr Wright’s compelling messages and no-nonsense delivery not only informs but inspires action, encouraging athletes and active people of all ages and skill levels to reclaim their health and thrive at every stage of life. Dr Wright practices orthopaedic surgery in Lake Nona Florida and is the founder and CEO of Precision Longevity. Her latest book, UNBREAKABLE, will be released in August of 2025.

Dr. Rangan Chatterjee – Functional Medicine Expert

Dr. Rangan Chatterjee is a Professor of Health Communication and Education at Chester Medical School and is known for his ability to simplify complex health information and inspire people to make positive changes in their lives. He hosts the most listened to health podcast in Europe 'Feel Better, Live More' which has had over 300 million listens to date and has published 6 #1 Sunday Times Bestselling books which have sold over 1 million copies worldwide. He is the only doctor globally to have successfully reversed type II diabetes, fibromyalgia, panic attacks, IBS and menopausal symptoms using only nutrition, lifestyle & mindset approaches on primetime TV, on his wildly successful BBC show ‘Doctor In The House’, which has been broadcast in over 70 countries around the world.

About iFIT Inc.

iFIT Inc. is a global leader in fitness technology, pioneering connected fitness to help people live longer, healthier lives. With a community of more than 6 million athletes around the world, iFIT delivers immersive, personalized workout experiences at-home, on the go, and in the gym. Powered by a comprehensive ecosystem of proprietary software, innovative hardware, and engaging content, the iFIT platform brings fitness to life through its portfolio of brands: NordicTrack, ProForm, Freemotion, and the iFIT app. From cardio and strength training to recovery, iFIT empowers athletes at every stage of their fitness journey. For more information, visit iFIT.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250528148121/en/

Contacts

Media
Edelman for iFIT
iFIT@edelman.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Nexo Announces Landmark Crypto Partnership with Tennis Australia for Australian Open and Summer of Tennis17.12.2025 09:00:00 CET | Press Release

Nexo, the premier digital assets platform, has entered a landmark multi-year global partnership with Tennis Australia, becoming the Official Crypto Partner of the Australian Open and the Summer of Tennis, including the United Cup, Adelaide International, Brisbane International, and Hobart International. This agreement marks the first time a digital asset company has partnered with a Grand Slam tournament, affirming Nexo’s prestige, long-term vision, and leadership at the intersection of elite sport and digital assets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216497915/en/ Antoni Trenchev, Co-founder, Nexo, noted: “The Australian Open stands at the intersection of excellence and ambition – precisely where Nexo positions itself. Our partnership reflects a shared commitment to disciplined performance and long-term thinking. We are honored to join Tennis Australia in elevating the sport while showcasing the value of int

Jerrod Chong, Yubico ’ s Chief Operating Officer, appointed as acting CEO17.12.2025 08:05:00 CET | Press Release

Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and the leading provider of hardware authentication security keys, today announced that Jerrod Chong, Yubico’s current Chief Operating Officer, has been appointed to serve as acting CEO. Mattias Danielsson will be stepping down from his role as CEO of Yubico. "I am very pleased that Jerrod has accepted the role of acting CEO. With his extensive experience in cybersecurity and twelve years in senior leadership at Yubico, I am confident that he will lead Yubico on a continued path of growth and he will ensure Yubico maintains and strengthens its leading position. On behalf of the board, I also want to extend our sincere thanks to Mattias Danielsson for his hard work and significant contributions to Yubico’s development as a respected leader and colleague over sixteen years. We deeply appreciate his commitment to Yubico over the years," says Patrik Tigerschiöld, Chairman of the Board. "Yubico is entering an excitin

VeritasChain Unveils VAP Architecture, New Auditability Research, and Confirms Submissions to 58 Regulators Globally17.12.2025 08:00:00 CET | Press Release

VeritasChain today unveiled its Verifiable AI Provenance Framework (VAP) architecture, published new research on verifiable audit trails, and confirmed informational submissions to 58 regulatory authorities across 43 jurisdictions. These milestones advance VeritasChain’s mission to establish a global framework for verifiable auditability in AI and algorithmic trading. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251216433807/en/ Map indicates jurisdictions where regulatory outreach or informational submissions have been made as of Dec 2025. Verifiable AI Provenance Framework (VAP) VAP is a layered assurance architecture designed for independent verification of AI decision-making. It is not a single product, but a framework defining how cryptographic evidence and third-party verification interoperate across diverse systems. The architecture records decision-to-execution events as immutable audit trails, facilitating regulat

Outpost24 Secures New Investment to Scale its Exposure Management and Identity Security Solutions17.12.2025 08:00:00 CET | Press Release

Outpost24, a leader in exposure management and identity security, today announced a new investment from Vitruvian Partners to fuel its next phase of global growth. This significant new funding will accelerate innovation across the company's platform, with a focus on integrating AI capabilities to optimize how security teams identify and neutralize critical vulnerabilities. The only European vendor recognized as an overall leader in the 2025 KuppingerCole Leadership Compass Report for Attack Surface Management, Outpost24 delivers a distinct approach to cyber defence that empowers security teams to gain a complete understanding of their digital and human risk landscape. Last week, Outpost24 announced the acquisition of Infinipoint, a specialist in device identity, posture validation, and secure workforce access. The acquisition marks the company's entry into the Zero Trust Workforce Access market and lays the foundation for its identity security division, Specops, to offer a unified appr

New Published Data Confirms Nemluvio ® (Nemolizumab) Can Rapidly Relieve Itch and Improve Sleep in as Early as Two Days in Both Atopic Dermatitis and Prurigo Nodularis17.12.2025 07:00:00 CET | Press Release

Galderma (SIX: GALD), the pure-play dermatology category leader, today released new clinical data confirming nemolizumab’s rapid onset of action on itch and sleep, with significant improvements observed as early as 48 hours after treatment in some patients with atopic dermatitis and prurigo nodularis.1 The findings from post-hoc analyses of the phase III ARCADIA and OLYMPIA clinical trial programs were published in the Journal of the European Academy of Dermatology and Venereology. Nemolizumab is the first approved monoclonal antibody that specifically targets IL-31 receptor alpha, inhibiting the signalling of IL-31.2,5,6 IL-31 is a neuroimmune cytokine that drives itch and other symptoms in both atopic dermatitis and prurigo nodularis.3,4 These new findings reinforce the critical role of IL-31 pathway inhibition in achieving rapid itch response. Atopic dermatitis and prurigo nodularis are debilitating skin conditions that significantly affect quality of life, with symptoms such as per

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye